Abstract
Background:
Pomegranate (Punica granatum) is a significant source of bioactive compounds. However, its toxicity is not intensively studied.Objectives:
The current study investigated the safety and tolerability of pomegranate peel extract (PPE) in BALB/c mice.Materials and Methods:
A total of 25 female BALB/c mice were randomly grouped. Each experimental group consisted of five animals. Repeated doses including 0.5, 1.9 and 7.5 mg/kg body weight of PPE were gavaged to BALB/c mice, for 22 days and the single intra-dermal injection (224 mg/kg) was done in one dose. The control group administrated with distilled water was also included. In addition, intra dermal injection for skin allergy testing was also performed. Blood was collected to evaluate glucose, cholesterol, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) as indicators of liver toxicity. Macroscopic and histopathological evaluation of tongue, trachea, and larynx tissues were also performed on 22 days post administration.Results:
Toxicological potential of PPE studies revealed no toxic effects, clinical signs, histopathological effect in epithelial cells layer of tongue, larynx and trachea, behavioral alterations and adverse effects or mortality in BALB/c mice. Repeated administrations did not alter or cause local irritation of the oral mucosa. Skin allergy test was negative in the last group.Conclusions:
The current study showed that PPE had no toxicity and its use is suggested with potential applications against diseases.Keywords
1. Background
Iran is considered rich in biodiversity. It is the home of original stocks of plant species with great commercial and medicinal values traditionally used for healing purposes.
The use of herbal medicine as a complementary and/or an alternative is increasing worldwide (1). However, it has been challenging since identification of active ingredients and analysis of its adverse effects is cumbersome (2). Pomegranate, Punica granatum L., is well-known for many therapeutic and pharmaceutical effects. PPE possess significant antioxidant, antimicrobial, antifungal, antiviral and cytotoxic activity in vitro models. It is also an important source of bioactive compounds. The largest components of the Punica granatum L. fruit extract are tannin and polyphenolics (3).
Middha et al. revealed polyphenolic and nutritive content, antioxidant activity, and phenolic profile of PPE. About five different flavonoids, phenolic acids, and their derivatives including quercetin, rutin, gallic acid, ellagic acid, and punicalagin as a major ellagitannin were identified by high-performance liquid chromatographic (HPLC) method (4).
Punica granatum L. has a long history to treat several conditions including diarrhea, ulcers, aphthae, hemorrhage, and respiratory complications (5, 6). PPE has diverse pharmacological functions such as antioxidant (7, 8), antifertility (9), cytotoxic (10, 11), hepatoprotective (12), and hypoglycemic activities, and tyrosinase inhibition (13, 14).
The study performed by Fawole et al. showed that PPE possesses strong antibacterial, antioxidant and anti-tyrosinase activities. Therefore the PPE could be exploited as a potential source of natural antimicrobial and antioxidant agents (15).
They are also used to treat parasitic and microbial infections. For example, the use of 250 μg/mL pomegranate peel extract (PPE) was most effective to inhibit antibiotic resistant strains of Salmonella typhimurium and Staphylococcus aureus in meat surfaces (16).
Al-Zoreky investigated the use of 80% methanolic pomegranate peel extract, which resulted in reduction of Listeria monocytogenes in fish during storage at 4°C (17). In addition, Shan et al. (18) indicated the effectiveness of pomegranate peel extract to inhibit the growth of L. monocytogenes, S. aureus, and Salmonella enterica in cheese at room temperature. Some other studies reported the use of pomegranate as a taeniacidal drug with high potency (19).
Punica granatum L. is rich in tannins and other biochemical compounds, particularly phenolics; and its peel contains high source of polyphenol compounds, which can reduce inflammation and other disease conditions (20, 21).
2. Objectives
The current study aimed to investigate the in vivo toxicity, safety and tolerability of pomegranate peel extract using BALB/c mice. This study allowed us to have a baseline for more in-depth studies on efficacy and safety of pomegranate peel extract for a possible application in the public health.
3. Materials and Methods
3.1. Plant Extraction
The sour malas cultivar of Persian Punica grantum L. peel used in the current study was collected from mature fruits grown in the Agricultural Research Center of Saveh, Iran. The results obtained in the previous studies demonstrated that among the various tested extract, sour malas peel extract showed maximum antifungal activity against various Candida strains. To prepare PPE, pomegranates were manually peeled, dried and powdered by a mixer grinder. Then, 50 grams of dried peel powder was added to 500 mL of 80% methanol for 10 days in a Soxhlet extraction apparatus. After extraction the solvent was removed, by means of a rotary evaporator, yielding the extracted compound. The stock peel extract was kept in sterile containers at 4°C until use.
3.2. Animal
A total of 25 BALB/c mice were prepared from the animal house of the Pasteur Institute of Iran, Tehran. Adult healthy female animals, eight to ten weeks old, weighing 22 - 25 g were used for animal studies. The mice were randomly grouped; each experimental group consisted of five animals. The animals were kept under standard laboratory conditions of temperature (25 ± 2°C), humidity 50% ± 5% and light/dark cycle (12 hours/12 hours). They were provided with a nutritionally adequate standard laboratory diet. The animals were housed in sanitized polypropylene cages containing sterile paddy husk as bedding. They had free access to standard pellet diet and water.
3.3. Experimental Design
The 22-day dietary toxicity study was performed to evaluate the repeated dose toxicity of PPE in twenty five BALB/c mice according to the standard protocols of organisation for economic Co-operation and development (OECD) guidelines 425 (22). Repeated doses were applied for a total of 22 days to determine the toxicity, tolerance or mortality. They were randomly assigned to five groups of five mice. The methanolic extract was gavaged to BALB/c mice in three doses, and injected intradermally in one dose. Groups of 20 female mice were administered 0.5, 1.9 and 7.5 mg pomegranate peel extract/kg body weight was diluted in a distilled water solution by gavages, six days per week for three weeks. One group received distilled water daily (2.8 mL/kg/daily) by gavages orally and was considered as the control. The doses were administered by oral route in mice as scheduled in OECD guidelines 425. In order to investigate the allergic reaction of P. granatum L. (pomegranate) peel extract, the single intra-dermal injection (224 mg/kg) was done.
Symptoms of toxicity and mortality were observed 24 hours after the administration followed by daily observation for 22 days. In vivo parameters, clinical chemistry parameters, hematology and pathology evaluations were conducted after 22 days.
3.4. Histopathological Sampling and Biochemical Analysis
Blood was collected intracardially from mice under ketamine (100 mg/kg) and xylazine (5 mg/kg) anesthesia and the separated serum was used for the estimation of glucose, alanine aminotransferase (ALT), aspartate aminotransferase (AST) and high-density lipoprotein (HDL) to determine the toxicity of pomegranate peel extract after 22 days of administration.
The animals were killed 24 hour after administration of the last gavages. Macroscopic examination of tongue, trachea and larynx tissues was performed after which they were quickly washed in isotonic saline and were collected and fixed in the neutral buffer contained formalin, distilled water, and phosphate mono and desodic (Na H2O, Na2 H2O) for histopathological examination. Histopathological evaluation of the epithelial cell layers of larynx, trachea and tongue were performed to determine the possible effects of cells exhibited by the pomegranate peel extract.
3.5. Statistical Analysis
Data were expressed as Mean ± standard error (SE). The student t-test was used to determine the significance among groups. A value of P < 0.05 was considered to be significant.
3.6. Ethical Considerations
All experimental procedures were reviewed and approved by the Animal Ethical Committee of Pasteur Institute of Iran, Tehran, prior to the initiation of the experiment and the laboratory animals were taken care of according to the committee for the purpose of control and supervision of experiments on animals (CPCSEA) regulations.
4. Results
The repeated oral administration by gavage produced no toxic effects in terms of weight gain, food intake, behavioral or biochemical parameters and irritation, inflammation and bleeding in the oral cavity or histopathological of epithelial cell layers of tongue, larynx and trachea. Administration of doses of 0.5, 1.9 and 7.5 mg/kg of pomegranate peel extract in BALB/c mice did not cause death in any of the animals. None of the animals exhibited any behavioral changes, and no toxic signs or symptoms were observed. Biochemical studies revealed no disturbances in glucose, cholesterol, ALT and AST following the administration of pomegranate peel extract. Punica granatum peel extract administered at the supra therapeutic dose (7.5 mg/kg) showed normal histopathological examinations with no inflammation. None of the animals developed any hematologic or biochemical abnormalities. All mice survived to the end of the study. No allergic reaction was shown after 24, 48 and 72 hours.
Figures 1 to 5 show that administration of PPE did not result in any significant changes in histopathological studies of epithelial cells of tongue, trachea and larynx tissues in various doses.
The stratified squamous epithelium of pharynx and sub-mucosal glands and seromucinous glands in BALB/c mice treated with 0.5 mg/kg b/w dose. H&E ×80.
The squamous epithelium of pharynx and seromucinous gland was normal in BALB/c mice treated with 0.5 mg/kg/day b/w dose. H&E ×80.
A histology section of ciliated epithelial of tongue shows the normal cells in BALB/c mice treated with 0.5 mg/kg/day b/w dose. H&E ×80.
The squamous epithelium, sub-mucosal and tongue muscle is normal in BALB/c mice treated with 1.9 mg/kg/day b/w dose. H&E ×80.
The photograph shows a vertical section of larynx, hyaline cartilage, squamous epithelium, and mucous glands are normal in BALB/c mice treated with 1.9 mg/kg/day b/w dose. H&E ×80.
A section of ciliated epithelial of tongue shows the normal cells in BALB/c mice treated with 7.5 mg/kg/day b/w dose. H&E ×80.
The stratified squamous epithelium of trachea and esophagus in BALB/c mice treated with 7.5 mg/kg/day b/w dose. H&E ×80.
The stratified squamous epithelium of tongue was normal in BALB/c mice (control group administrated distilled water). H&E ×80.
Microscopic morphology of the luminal epithelium of the esophagus in BALB/c mice (control group administrated distilled water). H&E ×80.
5. Discussion
Although traditional and herbal medicine may promise opportunities in the field of treatment of various diseases, their safety must always be considered. Pharmacological and toxicological evaluations of medicinal plants are essential for drug development (19, 20).
Pomegranate is interesting for researchers because of its chemical composition and biological properties. However, the toxicity of P. granatum is not intensively studied. Fuentes et al. (23) reported that pomegranate fruits were not toxic but pomegranate roots and bark were toxic. Amorin observed no toxic effects in mice treated with aqueous pomegranate extract (24).
According to the 22-day gavage study with repeated doses in BALB/c mice, the use of methanolic extract of P. granatum peel showed no toxicity when directly administered via the oral cavity under 7.5 mg/kg. The results obtained in the previous studies demonstrated that among the various tested extract, sour malas peel extract showed maximum antifungal activity against various Candida strains. Authors selected three doses to evaluate the PPE sour malas cultivar toxicity. The intermediate dose of PPE was the minimum inhibitory concentration (MIC) effect dose against Candida sp. in our previous study (25), we chose three doses to evaluate the pomegranate toxicity. The intermediate dose of pomegranate peel extract was based on the MIC effect doses against Candida sp. (25). Two other doses were then adjusted; the low dose did not induce any toxic responses and the high dose was sufficiently high to induce toxic responses in animal tests.
On the other hand, Vidal et al. (26) reported that the LD50 of 731 mg/kg was determined in mice after intra-peritoneal administration of P. granatum hydro alcoholic extract. The difference could be due to the fact that Vidal et al. used much higher doses than the ones used in the current study. The results of P. granatum peel extract tested on brine shrimp assay by Mehru et al. (27) indicated that the extract had a LC50 value greater than 1 mg/mL which is the recommended cutoff point to detect cytotoxic activity (28). Tripathi and Singh (29) found no statistically significant differences in LC50 values in snails (Lymnaea acuminata) after using various methods of extraction and different parts of the P. granatum plant. Overall, these studies may indicate that the extract of P. granatum were not toxic.
The genotoxicity of P. granantum was reported by Settheetham and Ishida who showed that in vitro use of aqueous pomegranate peel extract induced apoptosis in human cells (30). Amorin (24) did not observe genotoxic effects in mice treated orally with aqueous extract P. granantum at dose of l000 and 2000 mg/kg. Overall, it can be concluded that some parts of P. granatum extract may have toxic effect which could be related to its alkaloid content (29, 31) or pseudo pelletierine content (31). In the current study histopathological evaluation of tongue, trachea and larynx tissues exposed to pomegranate peel extract did not show remarkable morphological alterations such as cell disruption and atrophy when compared to the control group (Figures 1 - 9).
Other investigators observed the presence of ellagitannins, tannins and ellagic acid or their derivatives in P. granatum with anti-proliferative and apoptosis activities in many human cancer cell lines such as T24 (bladder), CaSki (cervical), MOLT-4 (leukaemia), MCF-7 and Hs 578T (breast), and DU 145 (prostate) cells (32-34). The study by Pena (35) on chick embryo showed that Punica granatum extract was not embryotoxic at the dose of 0.1 mg per embryo.
In conclusion, the lack of any adverse effects of pomegranate peel extract following its administration in mice suggested that this herbal product is safe and could be used to treat certain oral infections. The effectiveness of this extract against various fungal and bacterial infections is being determined.
Acknowledgements
References
-
1.
United Nations Conference on Trade and Development. 2000; Geneva. United Nations;
-
2.
Efferth T, Kaina B. Toxicities by herbal medicines with emphasis to traditional Chinese medicine. Curr Drug Metab. 2011;12(10):989-96. [PubMed ID: 21892916].
-
3.
Haslam E. Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J Nat Prod. 1996;59(2):205-15. [PubMed ID: 8991956]. https://doi.org/10.1021/np960040+.
-
4.
Middha SK, Usha T, Pande V. HPLC Evaluation of Phenolic Profile, Nutritive Content, and Antioxidant Capacity of Extracts Obtained from Punica granatum Fruit Peel. Adv Pharmacol Sci. 2013;2013:296236. [PubMed ID: 23983682]. https://doi.org/10.1155/2013/296236.
-
5.
Naqvi SAH, Khan MSY, Vohora SB. Anti-bacterial, anti-fungal and anthelmintic investigations on Indian medicinal plants. Fitoterapia. 1991;62:221-8.
-
6.
Caceres A, Giron LM, Alvarado SR, Torres MF. Screening of antimicrobial activity of plants popularly used in Guatemala for the treatment of dermatomucosal diseases. J Ethnopharmacol. 1987;20(3):223-37. [PubMed ID: 3682847].
-
7.
Li Y, Guo C, Yang J, Wei J, Xu J, Cheng S. Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract. Food chem. 2006;96(2):254-60.
-
8.
Thring TS, Hili P, Naughton DP. Anti-collagenase, anti-elastase and anti-oxidant activities of extracts from 21 plants. BMC Complement Altern Med. 2009;9:27. [PubMed ID: 19653897]. https://doi.org/10.1186/1472-6882-9-27.
-
9.
Gujral ML, Varma DR, Sareen KN. Oral contraceptives. Part I. Preliminary observations on the antifertility effect of some indigenous drugs. Indian J Med Res. 1960;48:46-51. [PubMed ID: 13830235].
-
10.
Sato A. Cancer chemotherapy with Oriental medicine (I): Antitumor activity of crude drugs with human tissue cultures in in vitro screening. Int J Orient Med. 1990;15(4):171-83.
-
11.
Kulkarni AP, Mahal HS, Kapoor S, Aradhya SM. In vitro studies on the binding, antioxidant, and cytotoxic actions of punicalagin. J Agric Food Chem. 2007;55(4):1491-500. [PubMed ID: 17243704]. https://doi.org/10.1021/jf0626720.
-
12.
Chidambara Murthy KN, Jayaprakasha GK, Singh RP. Studies on antioxidant activity of pomegranate (Punica granatum) peel extract using in vivo models. J Agric Food Chem. 2002;50(17):4791-5. [PubMed ID: 12166961].
-
13.
Dhawan BN, Patnaik GK, Rastogi RP, Singh KK, Tandon JS. Screening of Indian plants for biological activity: part VI. Indian J Exp Biol. 1977;15(3):208-19. [PubMed ID: 914326].
-
14.
Hontecillas R, O'Shea M, Einerhand A, Diguardo M, Bassaganya-Riera J. Activation of PPAR gamma and alpha by punicic acid ameliorates glucose tolerance and suppresses obesity-related inflammation. J Am Coll Nutr. 2009;28(2):184-95. [PubMed ID: 19828904].
-
15.
Fawole OA, Makunga NP, Opara UL. Antibacterial, antioxidant and tyrosinase-inhibition activities of pomegranate fruit peel methanolic extract. BMC Complement Altern Med. 2012;12:200. [PubMed ID: 23110485]. https://doi.org/10.1186/1472-6882-12-200.
-
16.
Tayel AA, El-Tras WF, Moussa SH, El-Sabbagh SM. Surface decontamination and quality enhancement in meat steaks using plant extracts as natural biopreservatives. Foodborne Pathog Dis. 2012;9(8):755-61. [PubMed ID: 22827400]. https://doi.org/10.1089/fpd.2012.1203.
-
17.
Al-Zoreky NS. Antimicrobial activity of pomegranate (Punica granatum L.) fruit peels. Int J Food Microbiol. 2009;134(3):244-8. [PubMed ID: 19632734]. https://doi.org/10.1016/j.ijfoodmicro.2009.07.002.
-
18.
Shan B, Cai YZ, Brooks JD, Corke H. Potential application of spice and herb extracts as natural preservatives in cheese. J Med Food. 2011;14(3):284-90. [PubMed ID: 21142945]. https://doi.org/10.1089/jmf.2010.0009.
-
19.
Desta B. Ethiopian traditional herbal drugs. Part I: Studies on the toxicity and therapeutic activity of local taenicidal medications. J Ethnopharmacol. 1995;45(1):27-33. [PubMed ID: 7739224].
-
20.
Sacheck J. Pediatric obesity: an inflammatory condition? JPEN J Parenter Enteral Nutr. 2008;32(6):633-7. [PubMed ID: 18974243]. https://doi.org/10.1177/0148607108324876.
-
21.
He J, Giusti MM. Anthocyanins: natural colorants with health-promoting properties. Annu Rev Food Sci Technol. 2010;1:163-87. [PubMed ID: 22129334]. https://doi.org/10.1146/annurev.food.080708.100754.
-
22.
2001.Guidelines for testing of chemicals, acute oral toxicity, Environmental Health and Safety Monograph Series on Testing and Adjustment.
-
23.
Fuentes V, Rodr’ıguez, N, Poucheaux, M, Cabrera, L, Lara, B. Estudios en la Medicina Tradicional en Cuba II. Revista Plantas Medicinales. 1985;5:13–40.
-
24.
Amorin A. Test of mutagenesis in mice treated with aqueous extracts from Punica granatum L. Revista Brasilena de Farmacia. 1995;74:110-1.
-
25.
Bassiri-Jahromi Shahindokht, Katiraee Farzad, Hajimahmoodi Mannan, Mostafavi Ehsan, Talebi Malihe, Pourshafie Mohammad Reza. In vitro antifungal activity of various Persian cultivars of Punica granatum L. extracts against Candida species. Jundishapur J Nat Pharm Prod. 2015;10(3). ee19754. https://doi.org/10.17795/jjnpp-19754.
-
26.
Vidal A, Fallarero A, Pena BR, Medina ME, Gra B, Rivera F, et al. Studies on the toxicity of Punica granatum L. (Punicaceae) whole fruit extracts. J Ethnopharmacol. 2003;89(2-3):295-300. [PubMed ID: 14611895].
-
27.
Mehru N, Rathinam X, Subramaniam S, Aiyalu R, Sreenivasan S, Reenivasan S, et al. Antimicrobial Activity and Toxicity of Punica granatum L. Peel. J Appl Biol Sci. 2008;2(3):57-9.
-
28.
Simionatto E, Porto C, Silva U, Squizani A, Dalcol II, Morel AF. Composition and antimicrobial activity of the essential oil from Aloysia sellowii. J Braz Chem Soc. 2005;16(6B):1458-62.
-
29.
Tripathi SM, Singh DK. Molluscicidal activity of Punica granatum bark and Canna indica root. Braz J Med Biol Res. 2000;33(11):1351-5. [PubMed ID: 11050667].
-
30.
Settheetham W, Ishida T. Study of genotoxic effects of antidiarrheal medicinal herbs on human cells in vitro. Southeast Asian J Trop Med Public Health. 1995;26 Suppl 1:306-10. [PubMed ID: 8629131].
-
31.
Ferrara L, Schettino O, Forgione P, Rullo V, Di Gennaro S. [Identification of the root of Punica granatum in galenic preparations using TLC]. Boll Soc Ital Biol Sper. 1989;65(5):385-90. [PubMed ID: 2775544].
-
32.
Flood A, Velie EM, Chaterjee N, Subar AF, Thompson FE, Lacey JJ, et al. Fruit and vegetable intakes and the risk of colorectal cancer in the Breast Cancer Detection Demonstration Project follow-up cohort. Am J Clin Nutr. 2002;75(5):936-43. [PubMed ID: 11976170].
-
33.
Larrosa M, Tomas-Barberan FA, Espin JC. The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutr Biochem. 2006;17(9):611-25. [PubMed ID: 16426830]. https://doi.org/10.1016/j.jnutbio.2005.09.004.
-
34.
Li TM, Chen GW, Su CC, Lin JG, Yeh CC, Cheng KC, et al. Ellagic acid induced p53/p21 expression, G1 arrest and apoptosis in human bladder cancer T24 cells. Anticancer Res. 2005;25(2A):971-9. [PubMed ID: 15868936].
-
35.
Pena BR. un extracto de frutos de Punica granatum L. con actividad contra el virus de la Influenza. University of Havana; 1998.